股本结构
单位:万股
公告日期 | 2023-05-12 | 2023-03-30 | 2022-11-10 | 2022-08-09 | 2022-08-10 | 2022-05-12 |
---|---|---|---|---|---|---|
证券总股本 | 365.23 | 365.23 | 363.92 | 338.71 | 338.72 | 331.09 |
普通股本 | 365.23 | 365.23 | 363.92 | 338.71 | 338.72 | 331.09 |
优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
变动日期 | 2023-03-31 | 2023-03-27 | 2022-09-30 | 2022-08-09 | 2022-06-30 | 2022-03-31 |
注释:中概股证券总股本=普通股股本/
存托凭证比例
历史变动
公告日期 | 变动后普通股本(万股) | 变动后优先股(万股) | 变动原因 | 变动日期 |
---|---|---|---|---|
2023-05-12 | 365.23 | 未披露 |
更多>>
From January 1, 2023 to March 31, 2023
Issuance of common stock, net of issuance costs
|
2023-03-31 |
2023-03-30 | 365.23 | 未披露 | 定期报告 | 2023-03-27 |
2022-11-10 | 363.92 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common stock, net of issuance costs
|
2022-09-30 |
2022-08-09 | 338.71 | 未披露 | 定期报告 | 2022-08-09 |
2022-08-10 | 338.72 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Conversion of preferred stock to common stock
|
2022-06-30 |
2022-04-29 | 338.72 | 未披露 | 定期报告 | 2022-04-18 |
2022-05-12 | 331.09 | 0.09 |
更多>>
From January 1, 2022 to March 31, 2022
Conversion of preferred stock to common stock
Adjustment due to reverse stock split
|
2022-03-31 |
2022-03-29 | 331.09 | 未披露 | 定期报告 | 2022-03-25 |
2022-02-24 | 329.83 | 未披露 |
更多>>
Pulmatrix, Inc. today announced a 1-for-20 reverse split of its common stock, to be effective as of 4:05 p.m. Eastern Time on February 28, 2022. The Company’s common stock is expected to trade on the Nasdaq Capital Market on a split-adjusted-basis when the market opens on March 1, 2022.
|
2022-03-01 |
2022-02-24 | 6596.57 | 未披露 | 定期报告 | 2022-02-15 |
2022-03-29 | 322.20 | 0.18 |
更多>>
From January 1, 2021 to December 31, 2021
Issuance of preferred stock and common stock warrants, net of issuance costs
Beneficial conversion feature of preferred stock
Deemed dividend related to beneficial conversion feature of preferred stock
Conversion of preferred stock to common stock
Issuance of common stock, net of issuance costs
Exercise of warrants
|
2021-12-31 |
2021-12-30 | 5624.91 | 0.67 | 定期报告 | 2021-12-17 |
2021-05-11 | 5624.91 | 未披露 |
更多>>
From January 1, 2021 to March 31, 2021
Issuance of common stock, net of issuance costs
Exercise of warrants
|
2021-03-31 |
2021-03-23 | 5624.91 | 未披露 | 定期报告 | 2021-03-19 |
2021-02-16 | 5610.51 | 未披露 |
更多>>
1.Common stock offered by the company 20,000,000 shares
2.The number of shares of common stock to be outstanding immediately after this offering is based on 36,105,097 shares of common stock outstanding as of February 10, 2021
|
2021-02-16 |
2021-03-23 | 3610.51 | 未披露 |
更多>>
from December 31, 2019 to December 31, 2020
Issuance of common stock, net of issuance costs
Exercise of warrants, net of issuance costs
Exercise of pre-funded warrants
Exercise of stock options
|
2020-12-31 |
2020-11-12 | 3440.75 | 未披露 |
更多>>
From June 30, 2020 to August 07, 2020
Exercise of warrants, net of issuance costs
|
2020-08-07 |
2020-08-07 | 3259.27 | 未披露 | 定期报告 | 2020-08-05 |
2020-08-07 | 2574.94 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock, net of issuance costs
Exercise of common stock options
Exercise of warrants
|
2020-06-30 |
2020-06-25 | 2560.88 | 未披露 | 定期报告 | 2020-06-24 |
2020-05-14 | 2542.13 | 未披露 | 定期报告 | 2020-05-12 |
2020-04-20 | 2531.14 | 未披露 |
更多>>
1.Common stock offered by us 4,787,553 shares
2.The number of shares of common stock to be outstanding immediately after this offering is based on 20,523,804 shares of our common stock outstanding as of April 16, 2020
|
2020-04-20 |
2020-04-20 | 2052.38 | 未披露 | 定期报告 | 2020-04-16 |
2020-05-14 | 2052.13 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Exercise of pre-funded warrants
Exercise of common stock options
Exercise of warrants
|
2020-03-31 |
2020-03-26 | 2052.13 | 未披露 | 定期报告 | 2020-03-24 |
2019-11-01 | 1999.46 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Exercise of pre-funded warrants
|
2019-09-30 |
2019-08-05 | 1962.46 | 未披露 |
更多>>
from March 31, 2019 to June 30, 2019
Issuance of common stock, net of issuance costs
Exercise of pre-funded warrants
|
2019-06-30 |
2019-05-15 | 1828.96 | 未披露 | 定期报告 | 2019-05-14 |
2019-05-15 | 802.79 | 未披露 |
更多>>
from January 1, 2019 to March 12, 2019
Adjustment for reverse stock split
Issuance of common stock, net of issuance costs
Exercise of pre-funded warrants
|
2019-03-12 |
2019-02-19 | 802.79 | 未披露 | 定期报告 | 2019-02-14 |
2019-02-06 | 538.02 | 未披露 |
更多>>
10比1的拆分导致股本变小
|
2019-02-06 |
2018-12-28 | 4932.72 | 未披露 | 定期报告 | 2018-12-26 |
2018-08-03 | 4692.72 | 未披露 | 定期报告 | 2018-06-30 |
2018-05-11 | 4192.72 | 未披露 | 定期报告 | 2018-05-09 |
2018-04-26 | 4024.02 | 未披露 | 定期报告 | 2018-04-06 |
2018-05-11 | 2228.02 | 未披露 | 定期报告 | 2018-03-31 |
2018-03-13 | 2228.02 | 未披露 | 定期报告 | 2018-03-08 |
2018-03-13 | 2104.75 | 未披露 |
更多>>
from December 31, 2016 to November 8, 2017
Issuance of common stock, net of issuance costs
Exercise of common stock options
Vesting of restricted stock units
|
2017-11-08 |
2017-11-09 | 2042.65 | 未披露 | 定期报告 | 2017-09-30 |
2017-08-04 | 2012.44 | 未披露 | 定期报告 | 2017-06-30 |
2017-05-05 | 1902.33 | 未披露 | 定期报告 | 2017-05-02 |
2017-04-28 | 1912.05 | 未披露 | 定期报告 | 2017-04-10 |
2017-05-05 | 1842.55 | 未披露 | 定期报告 | 2017-03-31 |
2017-03-10 | 1783.07 | 未披露 | 定期报告 | 2017-02-28 |
2017-02-06 | 1675.12 | 未披露 | 定期报告 | 2017-02-03 |
2017-03-10 | 1475.12 | 未披露 |
更多>>
From December 31, 2015 to December 31, 2016
Exercise of common stock options
Vesting of restricted stock units
|
2016-12-31 |
2016-11-04 | 1470.16 | 未披露 | 定期报告 | 2016-09-30 |
2016-08-04 | 1465.19 | 未披露 | 定期报告 | 2016-06-30 |
2016-05-05 | 1451.60 | 未披露 | 定期报告 | 2016-03-31 |
2016-04-14 | 1479.54 | 未披露 | 定期报告 | 2016-03-30 |
2016-03-10 | 1451.60 | 未披露 |
更多>>
From December 31, 2014 to December 31, 2015
Conversion of preferred stock into common stock
Conversion of convertible notes into common stock
Conversion of 2015 Bridge notes into common stock
Issuance of common stock and warrants
Issuance of warrant with term loan
Exercise of common stock options
Stock issued for consulting services in connection with the Merger
Exchange of common stock in connection with the Merger
Vesting of restricted stock units
On June 15, 2015, immediately following the Effective Time, we effected a 1-for-2.5 reverse stock split of our issued and outstanding Company Common Stock
|
2015-12-31 |
2015-11-12 | 1451.60 | 未披露 | 定期报告 | 2015-10-31 |
2015-11-12 | 1469.61 | 未披露 |
更多>>
from January 1, 2015 to September 30, 2015
Conversion of convertible notes into common stock
Conversion of 2015 Bridge notes into common stock
Issuance of common stock and warrants
Exercise of common stock options
Stock issued for consulting services in connection with the Merger
Exchange of common stock in connection with the Merger
Vesting of restricted stock units
Conversion of preferred stock into common stock
On June 15, 2015, immediately following the Effective Time, we effected a 1-for-2.5 reverse stock split of our issued and outstanding Company Common Stock
|
2015-09-30 |
2015-08-14 | 1451.60 | 未披露 | 定期报告 | 2015-07-31 |
2015-08-14 | 1464.61 | 未披露 |
更多>>
from January 1, 2015 to June 30, 2015
Conversion of preferred stock into common stock
Conversion of convertible notes into common stock
Conversion of 2015 Bridge notes into common stock
Issuance of common stock and warrants
Exercise of common stock options
Stock issued for consulting services in connection with the Merger
Exchange of common stock in connection with the Merger
Vesting of restricted stock units
On June 15, 2015, immediately following the Effective Time, we effected a 1-for-2.5 reverse stock split of our issued and outstanding Company Common Stock
|
2015-06-30 |
2015-08-14 | 1201.07 | 未披露 |
更多>>
On June 15, 2015, immediately following the Effective Time, we effected a 1-for-2.5 reverse stock split of our issued and outstanding Company Common Stock
|
2015-06-16 |
2014-08-14 | 480.43 | 未披露 |
更多>>
from March 31, 2014 to June 30, 2014
Shares issued for cash in connection with underwriter's exercise of overallotment, net
|
2014-06-30 |
2014-06-30 | 480.43 | 未披露 | 定期报告 | 2014-06-15 |
2014-06-30 | 465.00 | 未披露 |
更多>>
from March 31, 2013 to March 31, 2014
Shares and warrants issued for cash in connection with initial public offering
|
2014-03-31 |
2014-03-21 | 465.00 | 未披露 | 定期报告 | 2014-03-21 |
2013-10-16 | 200.00 | 未披露 |
更多>>
On September 25, 2013, the board of directors and the stockholders of the Company approved a 1-for-2.5 reverse stock split of the Company’s outstanding common stock, $0.0001 par value, which was effected on September 25, 2013
|
2013-09-26 |
2013-08-08 | 500.00 | 未披露 | 定期报告 | 2013-03-31 |
From January 1, 2023 to March 31, 2023
Issuance of common stock, net of issuance costs
From June 30, 2022 to September 30, 2022
Issuance of common stock, net of issuance costs
From March 31, 2022 to June 30, 2022
Conversion of preferred stock to common stock
From January 1, 2022 to March 31, 2022
Conversion of preferred stock to common stock
Adjustment due to reverse stock split
Pulmatrix, Inc. today announced a 1-for-20 reverse split of its common stock, to be effective as of 4:05 p.m. Eastern Time on February 28, 2022. The Company’s common stock is expected to trade on the Nasdaq Capital Market on a split-adjusted-basis when the market opens on March 1, 2022.
From January 1, 2021 to December 31, 2021
Issuance of preferred stock and common stock warrants, net of issuance costs
Beneficial conversion feature of preferred stock
Deemed dividend related to beneficial conversion feature of preferred stock
Conversion of preferred stock to common stock
Issuance of common stock, net of issuance costs
Exercise of warrants
From January 1, 2021 to March 31, 2021
Issuance of common stock, net of issuance costs
Exercise of warrants
1.Common stock offered by the company 20,000,000 shares
2.The number of shares of common stock to be outstanding immediately after this offering is based on 36,105,097 shares of common stock outstanding as of February 10, 2021
from December 31, 2019 to December 31, 2020
Issuance of common stock, net of issuance costs
Exercise of warrants, net of issuance costs
Exercise of pre-funded warrants
Exercise of stock options
From June 30, 2020 to August 07, 2020
Exercise of warrants, net of issuance costs
From March 31, 2020 to June 30, 2020
Issuance of common stock, net of issuance costs
Exercise of common stock options
Exercise of warrants
1.Common stock offered by us 4,787,553 shares
2.The number of shares of common stock to be outstanding immediately after this offering is based on 20,523,804 shares of our common stock outstanding as of April 16, 2020
From December 31, 2019 to March 31, 2020
Exercise of pre-funded warrants
Exercise of common stock options
Exercise of warrants
from June 30, 2019 to September 30, 2019
Exercise of pre-funded warrants
from March 31, 2019 to June 30, 2019
Issuance of common stock, net of issuance costs
Exercise of pre-funded warrants
from January 1, 2019 to March 12, 2019
Adjustment for reverse stock split
Issuance of common stock, net of issuance costs
Exercise of pre-funded warrants
10比1的拆分导致股本变小
from December 31, 2016 to November 8, 2017
Issuance of common stock, net of issuance costs
Exercise of common stock options
Vesting of restricted stock units
From December 31, 2015 to December 31, 2016
Exercise of common stock options
Vesting of restricted stock units
From December 31, 2014 to December 31, 2015
Conversion of preferred stock into common stock
Conversion of convertible notes into common stock
Conversion of 2015 Bridge notes into common stock
Issuance of common stock and warrants
Issuance of warrant with term loan
Exercise of common stock options
Stock issued for consulting services in connection with the Merger
Exchange of common stock in connection with the Merger
Vesting of restricted stock units
On June 15, 2015, immediately following the Effective Time, we effected a 1-for-2.5 reverse stock split of our issued and outstanding Company Common Stock
from January 1, 2015 to September 30, 2015
Conversion of convertible notes into common stock
Conversion of 2015 Bridge notes into common stock
Issuance of common stock and warrants
Exercise of common stock options
Stock issued for consulting services in connection with the Merger
Exchange of common stock in connection with the Merger
Vesting of restricted stock units
Conversion of preferred stock into common stock
On June 15, 2015, immediately following the Effective Time, we effected a 1-for-2.5 reverse stock split of our issued and outstanding Company Common Stock
from January 1, 2015 to June 30, 2015
Conversion of preferred stock into common stock
Conversion of convertible notes into common stock
Conversion of 2015 Bridge notes into common stock
Issuance of common stock and warrants
Exercise of common stock options
Stock issued for consulting services in connection with the Merger
Exchange of common stock in connection with the Merger
Vesting of restricted stock units
On June 15, 2015, immediately following the Effective Time, we effected a 1-for-2.5 reverse stock split of our issued and outstanding Company Common Stock
On June 15, 2015, immediately following the Effective Time, we effected a 1-for-2.5 reverse stock split of our issued and outstanding Company Common Stock
from March 31, 2014 to June 30, 2014
Shares issued for cash in connection with underwriter's exercise of overallotment, net
from March 31, 2013 to March 31, 2014
Shares and warrants issued for cash in connection with initial public offering
On September 25, 2013, the board of directors and the stockholders of the Company approved a 1-for-2.5 reverse stock split of the Company’s outstanding common stock, $0.0001 par value, which was effected on September 25, 2013